Clinical Trial Update: Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use [Phase 3]

View source ↗

Summary

Phase 3 compassionate-use trial update for Juvenile Idiopathic Arthritis sponsored by AbbVie. The study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-01-26